Literature DB >> 18486724

Ustekinumab for chronic plaque psoriasis.

Brenda L Bartlett1, Stephen K Tyring.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18486724     DOI： 10.1016/S0140-6736(08)60702-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

1.  Long-term ustekinumab therapy of psoriasis in patients with coexisting rheumatoid arthritis and Sjögren syndrome. Report of two cases and review of literature.

Authors:  Maria Sole Chimenti; Marina Talamonti; Lucia Novelli; Miriam Teoli; Marco Galluzzo; Paola Triggianese; Roberto Perricone
Journal:  J Dermatol Case Rep       Date:  2015-09-30

Review 2.  Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Authors:  Emilie Sbidian; Anna Chaimani; Ignacio Garcia-Doval; Giao Do; Camille Hua; Canelle Mazaud; Catherine Droitcourt; Carolyn Hughes; John R Ingram; Luigi Naldi; Olivier Chosidow; Laurence Le Cleach
Journal:  Cochrane Database Syst Rev       Date:  2017-12-22

Review 3.  Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Authors:  Emilie Sbidian; Anna Chaimani; Ignacio Garcia-Doval; Liz Doney; Corinna Dressler; Camille Hua; Carolyn Hughes; Luigi Naldi; Sivem Afach; Laurence Le Cleach
Journal:  Cochrane Database Syst Rev       Date:  2022-05-23

4.  MicroRNA-210 overexpression promotes psoriasis-like inflammation by inducing Th1 and Th17 cell differentiation.

Authors:  Ruifang Wu; Jinrong Zeng; Jin Yuan; Xinjie Deng; Yi Huang; Lina Chen; Peng Zhang; Huan Feng; Zixin Liu; Zijun Wang; Xiaofei Gao; Haijing Wu; Honglin Wang; Yuwen Su; Ming Zhao; Qianjin Lu
Journal:  J Clin Invest       Date:  2018-05-14       Impact factor: 14.808

5.  GLS1-mediated glutaminolysis unbridled by MALT1 protease promotes psoriasis pathogenesis.

Authors:  Xichun Xia; Guangchao Cao; Guodong Sun; Leqing Zhu; Yixia Tian; Yueqi Song; Chengbin Guo; Xiao Wang; Jingxiang Zhong; Wei Zhou; Peng Li; Hua Zhang; Jianlei Hao; Zhizhong Li; Liehua Deng; Zhinan Yin; Yunfei Gao
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

Review 6.  Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity.

Authors:  Manfred Kunz; Saleh M Ibrahim
Journal:  Mediators Inflamm       Date:  2009-10-26       Impact factor: 4.711

Review 7.  Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunology.

Authors:  Gérard Eberl; Marco Colonna; James P Di Santo; Andrew N J McKenzie
Journal:  Science       Date:  2015-05-21       Impact factor: 47.728

8.  Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Authors:  Emilie Sbidian; Anna Chaimani; Ignacio Garcia-Doval; Liz Doney; Corinna Dressler; Camille Hua; Carolyn Hughes; Luigi Naldi; Sivem Afach; Laurence Le Cleach
Journal:  Cochrane Database Syst Rev       Date:  2021-04-19

9.  Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Authors:  Emilie Sbidian; Anna Chaimani; Sivem Afach; Liz Doney; Corinna Dressler; Camille Hua; Canelle Mazaud; Céline Phan; Carolyn Hughes; Dru Riddle; Luigi Naldi; Ignacio Garcia-Doval; Laurence Le Cleach
Journal:  Cochrane Database Syst Rev       Date:  2020-01-09

10.  Integrating longitudinal serum IL-17 and IL-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcome.

Authors:  Julie Plée; Sébastien Le Jan; Jérôme Giustiniani; Coralie Barbe; Pascal Joly; Christophe Bedane; Pierre Vabres; François Truchetet; François Aubin; Frank Antonicelli; Philippe Bernard
Journal:  Sci Rep       Date:  2015-12-14       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.